HomeCOVID-19Vaccine Information
  • Distribution Schema

    Distribution Schema Graphic

  • Vaccine Update

    Team Yokota,

    We want to reassure you that the safety and well-being of our community is a top priority and the wing is working as quickly as possible to obtain enough vaccines to ensure that all eligible individuals who opt-in can be vaccinated. Thank you for your continued patience and understanding as the 374th Airlift Wing continues to distribute COVID-19 vaccines.

    To receive the most up to date information, please refer to our Facebook page, website or the USAF Connect App.

    Distribution Group

    Currently, we are vaccinating people who fall into Tier 1 (see attached) and are expecting to move into Tier 2 in the near future. If you fall into the current tier and have questions regarding your status, please contact your unit leadership. Additionally, beneficiaries over the age of 65 and high risk patients are managed by MDG Disease Management, DSN 225-2965.

    If you have any specific questions about the vaccine after reviewing the Emergency Use Authorization handout located on the CDC’s website, please contact your PCM.

    Schedule

    Please do not show up to a COVID-19 vaccine line unless you have been directly contacted by your unit leadership.

    When we move into Tier 2, we will provide details on COVID-19 vaccine lines.

    How to Schedule

    When we move into Tier 2, we will provide further instructions on how to schedule your vaccine.

    Vaccine Information

    Yokota Air Base is projected to receive the Janssen (Johnson & Johnson) COVID-19 vaccine soon and will be adding it to our vaccination rotation.  Yokota will soon have two different COVID-19 vaccines: Moderna and Janssen. 

    The Janssen COVID-19 Vaccine is a single-dose COVID-19 vaccine under Emergency Use Authorization from the FDA.  The vaccine is approved for individuals who are 18 years of age or older.  You should not get this vaccine if you have had any severe allergic reaction to any ingredient of the vaccine.  The Janssen COVID-19 Vaccine is 76.7% effective against severe/critical COVID-19 14 days vaccination and 85.4% effective after 28 days vaccination. Common and expected side effects following vaccination include injection site pain, headache, fatigue, body aches, nausea, and fever.  Side effects will resolve within 1-2 days following vaccination.  For more information, please go to https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/index.html.

    The Moderna COVID-19 Vaccine is a 2-series COVID-19 vaccine under Emergency Use Authorization from the FDA.  The vaccine is approved for individuals who are 18 years of age or older.  You should not get this vaccine if you have had any severe allergic reaction to any ingredient of the vaccine.  The Moderna COVID-19 Vaccine is 94.1% effective against COVID-19. Common and expected side effects following vaccination include injection site pain, headache, fatigue, body aches, nausea, and fever.  Side effects will resolve within 1-2 days following vaccination.  For more information, please go to https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html.

    If you have any moral or religious concerns, please call the Yokota Chapel at DSN 225-7009.

    If you have any questions, please refer to:

    -Yokota Air Base Facebook (@YokotaAirBase): https://www.facebook.com/yokotaairbase

    -Yokota Air Base Website: https://www.yokota.af.mil/COVID-19/

    -USAF Connect App